Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$4.87 - $17.29 $589,270 - $2.09 Million
-121,000 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$15.08 - $27.04 $301,600 - $540,800
-20,000 Reduced 14.18%
121,000 $1.99 Million
Q2 2020

Aug 12, 2020

SELL
$14.57 - $23.96 $1.07 Million - $1.76 Million
-73,500 Reduced 34.27%
141,000 $3.29 Million
Q1 2020

Apr 16, 2020

BUY
$10.27 - $21.23 $878,085 - $1.82 Million
85,500 Added 66.28%
214,500 $3.18 Million
Q4 2019

Jan 31, 2020

BUY
$8.36 - $23.81 $1.08 Million - $3.07 Million
129,000 New
129,000 $2.64 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.